Company Information

Company Zhejiang Raybow Pharmaceutical Co., LTD.
www.raybowpharma.com
Type:
Company
Country:
China
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
30 June 2021
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Communication On Progress

Published On Title Level/Status
31-Aug-2024 2024 Communication on Progress Submitted
29-Jun-2022 2022 COP Advanced

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.